Valente Manuela sold $21K of SOPH
Valente Manuela (Chief People Officer) sold 4,241 shares of SOPHiA GENETICS SA (SOPH) at $5.05 on 2026-07-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price, and post-transaction holdings by the Chief People Officer under a pre-arranged 10b5-1 plan.
Market read
Traders may note the disclosed sale, but the 10b5-1 framing and small dollar value reduce actionable signal.
What to watch
Insider sales can be tax- or diversification-driven; the article provides no context on motivations beyond the pre-arranged plan.
Background
The article is an SEC Form 4 insider transaction disclosure for SOPHiA GENETICS SA.
Ticker impact
SOPHiA GENETICS insider Valente Manuela sold 4,241 shares in an open-market transaction on 2026-07-06 for ~$21.4K.
Likely minimal price impact; any effect would be sentiment-only and short-lived.
The filing is a small, disclosed insider sale under a pre-arranged 10b5-1 plan, with no accompanying guidance, deal, or regulatory event.
Market effects
No clear sector read-through; this is an individual insider transaction without new company disclosures.
None indicated.
None indicated.
Counterpoint
Because it’s a 10b5-1 plan, the sale may be mechanically scheduled and not a bearish signal; traders may ignore it unless paired with other negative disclosures.
Key entities
- issuerSOPHiA GENETICS SA
Company whose insider transaction was disclosed on SEC Form 4.
- insiderValente Manuela
Chief People Officer who sold 4,241 shares in an open-market transaction.
